carried

acquired: ▪ On 31 May 2019, MAB carried out the transfer of a portfolio of long-term savings and credit life insurance from Alpha Insurance SA, a Belgian composite insurance company and a wholly-owned subsidiary of Enstar Group Limited, (the “Alpha Portfolio”, or “Alpha”) (20,456 policies as at 31 December 2025). ▪ On 16 December 2019, MAB carried out the transfer of a portfolio of non-Curanova long term savings contracts from Curalia OVV (the “NCN Portfolio” and “Curalia”, respectively

following life insurance portfolios were acquired: ▪ On 31 May 2019, MAB carried out the transfer of a portfolio of long-term savings and credit life insurance from Alpha Insurance SA, a Belgian composite insurance company and a wholly-owned subsidiary of Enstar Group Limited, (the “Alpha Portfolio”, or “Alpha”) (22,549 policies as at 31 December 2024). ▪ On 16 December 2019, MAB carried out the transfer of a portfolio of non-Curanova long term savings contracts from Curalia OVV (the “NCN Portfolio

-force life insurance portfolios. This strategy is focused on closed books. Consistent with this strategy the following life insurance portfolios were acquired: ▪ On 31 May 2019, MAB carried out the transfer of a portfolio of long-term savings and credit life insurance from Alpha Insurance SA, a Belgian composite insurance company and a wholly-owned subsidiary of Enstar Group Limited, (the “Alpha Portfolio”, or “Alpha”) (24,879 policies as at 31 December 2023). ▪ On 16 December 2019, MAB carried

to applicable data protection laws and regulations. We do not process your personal data for purposes incompatible with those notified to you through this notice. Each processing operation is carried out on a single legal basis. We determine the

reporting period from € 14.0m to € 313m. This increase was principally due to the following 3 actions done over the year 2021: ▪ following the acquisition of the Allianz portfolio in April 2021, a capital injection of € 45m was carried out; ▪ following the acquisition of the Integrale portfolio in December 2021, a second capital injection of € 225m was carried out; ▪ for the acquisition of the Integrale book, MAB received more assets than liabilities, generating additional available own funds

reporting period from €312,9m to € 372,1m. This increase was principally due to the acquisition of the AXA portfolio in October 2022 where a capital injection of €50m was carried out. The SCR increased from € 127,4m to € 147,7m over the reporting period